The Chart for MEI Pharma Inc. (MEIP) Is Flashing Mixed Signals – News Heater
Home  »  Hot Stocks   »  The Chart for MEI Pharma Inc. (MEIP) Is Flashing M...

The Chart for MEI Pharma Inc. (MEIP) Is Flashing Mixed Signals

MEI Pharma Inc. (NASDAQ:MEIP) went up by 2.86% from its latest closing price compared to the recent 1-year high of $3.55. The company’s stock price has collected 21.79% of gains in the last five trading sessions.

Is It Worth Investing in MEI Pharma Inc. (NASDAQ :MEIP) Right Now?

Plus, the 36-month beta value for MEIP is at 1.09. Opinions of the stock are interesting as 5 analysts out of 9 who provided ratings for MEI Pharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $4.81, which is $4.58 above the current price. MEIP currently public float of 132.49M and currently shorts hold a 7.87% ratio of that float. Today, the average trading volume of MEIP was 7.40M shares.

MEIP’s Market Performance

MEIP stocks went up by 21.79% for the week, with a monthly jump of 20.53% and a quarterly performance of -68.19%, while its annual performance rate touched -82.10%. The volatility ratio for the week stands at 11.57% while the volatility levels for the past 30 days are set at 12.44% for MEI Pharma Inc. The simple moving average for the period of the last 20 days is 14.63% for MEIP stocks with a simple moving average of -69.45% for the last 200 days.

Analysts’ Opinion of MEIP

Many brokerage firms have already submitted their reports for MEIP stocks, with Wells Fargo repeating the rating for MEIP by listing it as a “Equal Weight.” The predicted price for MEIP in the upcoming period, according to Wells Fargo is $2 based on the research report published on March 25th of the current year 2022.

Stifel, on the other hand, stated in their research note that they expect to see MEIP reach a price target of $2, previously predicting the price at $6. The rating they have provided for MEIP stocks is “Hold” according to the report published on March 25th, 2022.

Jefferies gave a rating of “Hold” to MEIP, setting the target price at $1 in the report published on March 25th of the current year.

MEIP Trading at 10.52% from the 50-Day Moving Average

After a stumble in the market that brought MEIP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.51% of loss for the given period.

Volatility was left at 12.44%, however, over the last 30 days, the volatility rate increased by 11.57%, as shares surge +29.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.20% upper at present.

During the last 5 trading sessions, MEIP rose by +21.79%, which changed the moving average for the period of 200-days by -79.75% in comparison to the 20-day moving average, which settled at $0.5172. In addition, MEI Pharma Inc. saw -78.08% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for MEIP

Current profitability levels for the company are sitting at:

  • -272.90 for the present operating margin
  • +94.49 for the gross margin

The net margin for MEI Pharma Inc. stands at -198.06. The total capital return value is set at -108.99, while invested capital returns managed to touch -79.68. Equity return is now at value -64.30, with -18.50 for asset returns.

Based on MEI Pharma Inc. (MEIP), the company’s capital structure generated 20.06 points at debt to equity in total, while total debt to capital is 16.71. Total debt to assets is 4.77, with long-term debt to equity ratio resting at 17.82. Finally, the long-term debt to capital ratio is 14.84.

When we switch over and look at the enterprise to sales, we see a ratio of -1.54, with the company’s debt to enterprise value settled at 0.05. The receivables turnover for the company is 1.64 and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.44.

Is Canoo Inc. (GOEV) a Keeper?

Canoo Inc. (NASDAQ:GOEV) went down by -4.23% from its latest closing price compared to the recent 1-year high of $13.35. The company’s stock price has